Live Covid-19 Live Updates: U.S. Air Travel to Vacation Spots Is Returning With all adults in the U.S. soon eligible for vaccination, the path out of the pandemic is clear. Johnson & Johnson has moved to strengthen its control over Emergent BioSolutions’ work to avoid additional quality lapses. The problems arose in a new plant that the federal government enlisted last year to produce vaccines from Johnson & Johnson and AstraZeneca. Johnson & Johnson reported the mishap to federal regulators, who then started an investigation that has delayed the authorization of that plant’s production lines. But that depends on whether Johnson & Johnson satisfies Food and Drug Administration regulators.

Source: International New York Times April 01, 2021 09:03 UTC